Regorafenib (BAY73-4506)
15808
Phase 3 small_molecule completed
Quick answer
Regorafenib (BAY73-4506) for Colorectal Neoplasms is a Phase 3 program (small_molecule) at Bayer HealthCare AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer HealthCare AG
- Indication
- Colorectal Neoplasms
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed